Wellness & Lifestyle

Memorize the “Anaphylactic Shock” Emergency Resuscitation Sequence to Easily Handle Critical Emergency Cases!

By Dr.Paul 08/03/2025

Severe allergic reaction refers to a sudden, severe, potentially life-threatening systemic allergic reaction in the…

Wellness & Lifestyle

Norfloxacin, Levofloxacin, Moxifloxacin: 3 Minutes to Understand the Differences, Misuse Harms Your Health!

By Dr.Paul 08/03/2025

"Take Norfloxacin for diarrhea, Levofloxacin for urinary tract infections, and Moxifloxacin for pneumonia" – this…

Medical News Wellness & Lifestyle

Dexamethasone: Essential Precautions and Key Drug Interactions to Know

By MedXY 08/03/2025

Dexamethasone is a powerful corticosteroid that requires careful use due to potential harmful drug interactions and side effects. This article highlights crucial precautions and compatibility issues for safe administration.

Medical News Wellness & Lifestyle

Ibuprofen vs. Acetaminophen: Which Fever Reducer is Right for You?

By MedXY 08/03/2025

Explore the differences, uses, and safety of ibuprofen and acetaminophen for managing fever effectively.

Clinical Updates Wellness & Lifestyle

Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Haemoglobinuria: 48-Week Outcomes from APPLY-PNH and APPOINT-PNH Phase 3 Trials

By MedXY 08/03/2025

Oral iptacopan provides sustained haemolysis control and improved haemoglobin in PNH patients over 48 weeks, with a favorable safety profile, supporting its role as a new therapeutic option.

Clinical Updates Wellness & Lifestyle

Oral Regimens for Whipple’s Disease: A Non-Inferiority Trial of Doxycycline-Hydroxychloroquine Versus Standard Intravenous Therapy

By MedXY 08/03/2025

A German phase 2/3 trial found oral doxycycline-hydroxychloroquine as effective and safe as standard intravenous ceftriaxone followed by oral trimethoprim-sulfamethoxazole for Whipple’s disease, potentially transforming outpatient management.

Clinical Updates Wellness & Lifestyle

Dissecting Depression in Diabetes: Distinct Links of Somatic and Cognitive Symptoms with Inflammation and Insulin Resistance

By MedXY 08/03/2025

New GRADE sub-study reveals that somatic symptoms of depression, not cognitive-affective symptoms, are chiefly associated with inflammation and insulin resistance in type 2 diabetes, highlighting a pathophysiological bridge for targeted interventions.

Clinical Updates Wellness & Lifestyle

Seasonal Malaria Chemoprevention in Uganda: Efficacy of SPAQ and Dihydroartemisinin-Piperaquine in the Era of Drug Resistance

By MedXY 08/03/2025

A large cluster-randomised trial in Uganda demonstrates that both SPAQ and dihydroartemisinin-piperaquine are highly effective and safe for seasonal malaria chemoprevention in children, with no evidence of resistance selection.

Clinical Updates Wellness & Lifestyle

Selumetinib for Adults with NF1-Associated Inoperable Plexiform Neurofibromas: Results from the KOMET Phase 3 Trial

By MedXY 08/03/2025

The KOMET phase 3 trial shows selumetinib offers significant tumor response in adults with NF1 and inoperable plexiform neurofibromas, with a manageable safety profile.

Clinical Updates Wellness & Lifestyle

Relacorilant Plus Nab-Paclitaxel: A New Standard for Platinum-Resistant Ovarian Cancer?

By MedXY 08/03/2025

Relacorilant combined with nab-paclitaxel significantly improved progression-free and overall survival in platinum-resistant ovarian cancer, with a favorable safety profile, suggesting a potential new treatment standard.